Neuroscience
This Canadian National Post report, among many yesterday and today, outlines ANS [company website] and Cyberonics [company website] issues:
- Rfid In Neurotech
“You have to void yourself of prejudices, pre-conceived ideas or whether you’ve seen this type of person before when it’s time to get to work on something,” said Marlin Mickle. “Because if you don’t, your mind starts to focus on that and you...
- Business World: Cyberonics, Neurostimulator (vagus Nerve Stimulator [vns]), And Depression
News about this controversial issue (See the list at the bottom of this posting for earlier BrainBlog posts.) From the company's press release:FDA APPROVES CYBERONICS’ VNS THERAPY™ SYSTEM FOR TREATMENT-RESISTANT DEPRESSION (TRD) First FDA-Approved...
- Business World: Cyberonics And Neurostimulators (vagal Nerve Stimulator [vns])
Tomorrow's New York Times includes an article about the current state of FDA consideration of the Cyberonics VNS device for the treatment of depression. The article is notable for the number of interviews across the spectrum of opinion on this pending...
- Business World: Cyberonics And Neurostimulators (vagal Nerve Stimulator [vns])
From Reuters: Cyberonics falls as Senate probes FDA turnaround Thu May 19, 2005 10:07 AM ET CHICAGO (Reuters) - Shares of Cyberonics Inc. fell almost 13 percent on Thursday after the Senate Finance Committee began examining the FDA's handling of...
- Vagal Nerve Stimulator And Depression
From The New York Times: F.D.A. May Approve an Implant as a Treatment for Depression By BARNABY J. FEDER The New York Times Published: February 4, 2005 The Food and Drug Administration said yesterday that it might permit an implantable electrical...
Neuroscience
Business World: Neuromodulation
This Canadian National Post report, among many yesterday and today, outlines ANS [company website] and Cyberonics [company website] issues:
Advanced Neuromodulation Systems bids US$22 a share for Cyberonics
Canadian Press (copyright)
Thursday, September 16, 2004
DALLAS (AP) - Advanced Neuromodulation Systems Inc. said Wednesday that it offered to buy fellow medical-device maker Cyberonics Inc. for $22 US a share, putting a price on the business combination it proposed last month.
The combination of the only two publicly held companies solely devoted to neuromodulation would make them both more competitive and lead to more innovation in the field, said Chris Chavez, president and chief executive of ANS, in a statement.
Neuromodulation uses implanted devices to stimulate and manipulate nervous system response. ANS makes radio-wave devices that disrupt pain signals sent by the nervous system. Cyberonics makes a device for epileptics that is implanted under the collarbone and helps control seizures by stimulating the vagus nerve.
ANS said its cash-and-stock offer represents a premium of 47 per cent over Cyberonics' closing price of $14.95 US on Aug. 19 and a premium of 29 per cent over the closing price of $17.05 on Sept. 13.
ANS reported on Aug. 20 that it had acquired 14.9 per cent of Cyberonics' outstanding common stock and said then that it hoped to combine the two companies. Cyberonics said at that time that it had no interest in any business combination or merger.
[ ... Read the full report ...]
- Rfid In Neurotech
“You have to void yourself of prejudices, pre-conceived ideas or whether you’ve seen this type of person before when it’s time to get to work on something,” said Marlin Mickle. “Because if you don’t, your mind starts to focus on that and you...
- Business World: Cyberonics, Neurostimulator (vagus Nerve Stimulator [vns]), And Depression
News about this controversial issue (See the list at the bottom of this posting for earlier BrainBlog posts.) From the company's press release:FDA APPROVES CYBERONICS’ VNS THERAPY™ SYSTEM FOR TREATMENT-RESISTANT DEPRESSION (TRD) First FDA-Approved...
- Business World: Cyberonics And Neurostimulators (vagal Nerve Stimulator [vns])
Tomorrow's New York Times includes an article about the current state of FDA consideration of the Cyberonics VNS device for the treatment of depression. The article is notable for the number of interviews across the spectrum of opinion on this pending...
- Business World: Cyberonics And Neurostimulators (vagal Nerve Stimulator [vns])
From Reuters: Cyberonics falls as Senate probes FDA turnaround Thu May 19, 2005 10:07 AM ET CHICAGO (Reuters) - Shares of Cyberonics Inc. fell almost 13 percent on Thursday after the Senate Finance Committee began examining the FDA's handling of...
- Vagal Nerve Stimulator And Depression
From The New York Times: F.D.A. May Approve an Implant as a Treatment for Depression By BARNABY J. FEDER The New York Times Published: February 4, 2005 The Food and Drug Administration said yesterday that it might permit an implantable electrical...